US Patent Issued to Board of Regents, The University of Texas System, Takeda Pharmaceutical on May 27 for "BCMA chimeric antigen receptors and uses thereof" (Texas, Massachusetts Inventors)

ALEXANDRIA, Va., June 17 -- United States Patent no. 12,310,988, issued on May 27, was assigned to Board of Regents, The University of Texas System (Austin, Texas) and Takeda Pharmaceutical Co. Ltd. (Osaka, Japan).

"BCMA chimeric antigen receptors and uses thereof" was invented by Katy Rezvani (Houston), Rafet Basar (Houston), Paul Lin (Houston), Michael David Curley (Cambridge, Mass.), LeeAnn Talarico (Cambridge, Mass.), Prashanth Vishwanath (Cambridge, Mass.) and James Wilson Meador III (Cambridge, Mass.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present application provides BCMA targeting chimeric antigen receptor (CAR) comprising a BCMA binding region and an intracellular costimulatory domain der...